Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bruce Rosen who wrote (6438)	4/27/1999 6:54:00 AM
From: Linda Kaplan	Read Replies (1) \| Respond to of 7041

Thanks for your comments. Good points. --Linda

To: Bruce Rosen who wrote (6438)	4/29/1999 7:57:00 AM
From: Linda Kaplan	Respond to of 7041

Looks to me that the price fluctuations in the past few trading days were due to speculation about the earnings, but unless I'm missing something, the earnings weren't good. No additional sales in Mexico after that first quarter. I predict that is prototypical of what will happen if the drug is approved in the US. Sales the first quarter and then no more sales. I think it will just take two quarters after approval for the stock to totally tank, not four. Linda